Cite
Retraction Note: TLE3 represses colorectal cancer proliferation by inhibiting MAPK and AKT signaling pathways.
MLA
Yang, Run-Wei, et al. “Retraction Note: TLE3 Represses Colorectal Cancer Proliferation by Inhibiting MAPK and AKT Signaling Pathways.” Journal of Experimental & Clinical Cancer Research (17569966), vol. 40, no. 1, Sept. 2021, p. 1. EBSCOhost, https://doi.org/10.1186/s13046-021-02079-2.
APA
Yang, R.-W., Zeng, Y.-Y., Wei, W.-T., Cui, Y.-M., Sun, H.-Y., Cai, Y.-L., Nian, X.-X., Hu, Y.-T., Quan, Y.-P., Jiang, S.-L., Wang, M., Zhao, Y.-L., Qiu, J.-F., Li, M.-X., Zhang, J.-H., He, M.-R., Liang, L., Ding, Y.-Q., & Liao, W.-T. (2021). Retraction Note: TLE3 represses colorectal cancer proliferation by inhibiting MAPK and AKT signaling pathways. Journal of Experimental & Clinical Cancer Research (17569966), 40(1), 1. https://doi.org/10.1186/s13046-021-02079-2
Chicago
Yang, Run-Wei, Ying-Yue Zeng, Wen-Ting Wei, Yan-Mei Cui, Hui-Ying Sun, Yue-Long Cai, Xin-Xin Nian, et al. 2021. “Retraction Note: TLE3 Represses Colorectal Cancer Proliferation by Inhibiting MAPK and AKT Signaling Pathways.” Journal of Experimental & Clinical Cancer Research (17569966) 40 (1): 1. doi:10.1186/s13046-021-02079-2.